View in EDS HTML Full Text PDF Full Text

Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies.

Saved in:
Bibliographic Details
Title: Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies.
Authors: Avila-Herrera, Aram1 (AUTHOR), Kimbrel, Jeffrey A.2 (AUTHOR), Manuel Martí, Jose1 (AUTHOR), Thissen, James2 (AUTHOR), Saada, Edwin A.2 (AUTHOR), Weisenberger, Tracy2 (AUTHOR), Arrildt, Kathryn T.2 (AUTHOR), Segelke, Brent W.2 (AUTHOR), Allen, Jonathan E.1 (AUTHOR), Zemla, Adam1 (AUTHOR), Borucki, Monica K.2 (AUTHOR) borucki2@llnl.gov
Source: PLoS ONE. 1/25/2024, Vol. 19 Issue 1, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0289198